Genomadix
2 known investors
Find your way into Genomadix
Sign up to find every way you can get introduced to Genomadix
- Your email: who you already know at Genomadix, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Genomadix team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.
Investors · 2
Also in the syndicate · 1
ICW Ventureslead
Funding
SEC filings, press & company announcements- Undisclosed amountseed roundJul 2022
ICW Ventures (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Genomadix do?
- Genomadix develops the Cube, a point-of-care PCR platform for real-time molecular testing in precision medicine and environmental applications. The company commercializes FDA-cleared genotyping tests and offers its open platform for partnerships with assay developers and clinical laboratories.
- Who are Genomadix's investors?
- Genomadix's investors include UCeed Funds.
